Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDICHOPE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   15.4% 18.7% 16.5% 11.3% 19.0% 13.4% 16.3% 16.3%   Credit score (0-100)   14 8 10 20 6 16 11 11   Credit rating   BB B BB BB B BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   174 205 243 176 142 154 0.0 0.0   EBITDA   25.2 -50.2 10.3 147 -36.3 40.6 0.0 0.0   EBIT   25.2 -50.2 10.3 147 -36.3 40.6 0.0 0.0   Pre-tax profit (PTP)   25.2 -50.2 9.8 146.7 -37.6 40.6 0.0 0.0   Net earnings   23.5 -39.3 7.6 114.4 -29.4 31.7 0.0 0.0   Pre-tax profit without non-rec. items   25.2 -50.2 9.8 147 -37.6 40.6 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   134 94.6 102 217 187 219 169 169   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   183 181 252 300 242 307 169 169   Net Debt   -33.3 -38.9 -76.1 -55.2 -9.8 -27.2 -169 -169     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   174 205 243 176 142 154 0.0 0.0   Gross profit growth   -22.5% 17.7% 18.5% -27.6% -19.4% 8.2% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   183 181 252 300 242 307 169 169   Balance sheet change%   -14.9% -0.9% 39.4% 19.0% -19.2% 26.7% -45.0% 0.0%   Added value   25.2 -50.2 10.3 147.4 -36.3 40.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 -1.0 1.0 2.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   14.4% -24.4% 4.2% 83.7% -25.6% 26.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   12.7% -27.6% 4.8% 53.4% -13.4% 14.8% 0.0% 0.0%   ROI %   20.6% -42.5% 10.1% 92.5% -18.0% 20.0% 0.0% 0.0%   ROE %   19.3% -34.4% 7.7% 71.8% -14.6% 15.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   73.3% 52.3% 40.5% 72.2% 77.3% 71.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -132.5% 77.5% -739.6% -37.4% 27.1% -67.0% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.7 0.6 0.6 0.7 0.3 0.3 0.0 0.0   Current Ratio   3.7 2.3 1.7 3.6 4.4 3.5 0.0 0.0   Cash and cash equivalent   33.3 38.9 76.1 55.2 9.8 27.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   133.9 102.1 102.2 216.6 187.2 218.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   25 -50 10 147 -36 41 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   25 -50 10 147 -36 41 0 0   EBIT / employee   25 -50 10 147 -36 41 0 0   Net earnings / employee   24 -39 8 114 -29 32 0 0